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A Cathepsin L Isoform that Is Devoid of a Signal
Peptide Localizes to the Nucleus in S Phase and
Processes the CDP/Cux Transcription Factor
terminal degradation of proteins in the lysosomes, but
the specific phenotypes resulting from gene inactivation
of different cathepsin genes have suggested that dis-
tinct cathepsins may play specific, nonredundant, phys-
iological functions involving particular tissues or cell
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specific protein), can efficiently inhibit a nuclear papain-
like cysteine protease and cause a block in cellular pro-
liferation (Irving et al., 2002). However, there is at presentSummary
no direct evidence for the presence of a cathepsin in
the nucleus.The subclass of cysteine proteases termed lysosomal
The CDP/Cux/Cut transcription factors are a familycathepsins has long been thought to be primarily
of homeodomain proteins that are conserved amonginvolved in end-stage protein breakdown within lyso-
metazoans (reviewed in Nepveu, 2001). Genetic analysissomal compartments. Furthermore, few specific pro-
in Drosophila melanogaster indicated that cut mediatestein substrates for these proteases have been identi-
phenotypic effects in a large number of tissues (Bodmerfied. We show here that cathepsin L functions in the
et al., 1987; Liu et al., 1991). Inactivation of cux-1 by generegulation of cell cycle progression through proteo-
targeting in the mouse has revealed several phenotypes,lytic processing of the CDP/Cux transcription factor.
including growth retardation, delayed differentiation ofCDP/Cux processing in situ was increased following
lung epithelia, altered hair follicle morphogenesis, maleectopic expression of cathepsin L but was reduced in
infertility, and a deficit in T and B cells (Ellis et al., 2001;Cat L/ cells. Furthermore, catalytically active ca-
Luong et al., 2002; Sinclair et al., 2001). In contrast tothepsin L was localized to the nucleus during the G1-S
the small size of cux-1 knockout mice, transgenic micetransition as detected by immunofluorescence im-
expressing cux-1 displayed multiorgan hyperplasia andaging and labeling using activity-based probes. Traf-
organomegaly (Ledford et al., 2002). Thus, from geneticficking of cathepsin L to the nucleus is accomplished
studies both in Drosophila and the mouse, it is clearthrough a mechanism involving translation initiation at
that the CDP/Cux/Cut gene plays an important role indownstream AUG sites and the synthesis of proteases
tissue homeostasis in several organs.that are devoid of a signal peptide. Overall, these re-
A role for CDP/Cux in cell cycle progression, in partic-
sults uncover an as yet unsuspected role for cysteine
ular at the G1/S transition, was inferred from a number
proteases in the control of cell cycle progression. of evidence. In particular, CDP/Cux binding to DNA in-
creases at the G1/S transition (Coqueret et al., 1998;
Introduction Holthuis et al., 1990; van Wijnen et al., 1996). This in-
crease in DNA binding involves two regulatory events:
Mammalian cysteine proteases of the papain family are dephosphorylation of the Cut homeodomain by the
targeted to the lumen of the endoplasmic reticulum via Cdc25A phosphatase and a specific proteolytic cleav-
a signal peptide within their prodomain and are subse- age (Coqueret et al., 1998; Moon et al., 2001). As cells
quently glycosylated, phosphorylated, and trafficked to progress into S phase, a fraction of CDP/Cux p200 mole-
the lysosomes (Chapman et al., 1997a). These proteases cules is proteolytically processed into N-terminally trun-
have long been thought to function exclusively in the cated proteins of 110 kDa. While CDP/Cux p200 only
transiently binds to DNA and carries the CCAAT-dis-
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and enzymes involved in proteolytic processing of CDP/ starvation-restimulation and the timing of their entry into
S phase was monitored. Cells expressing CDP/Cux p110Cux within the nucleus have remained largely unknown.
In the present study, we have used a number of strate- started to enter in S phase at 14 hr following serum
addition, whereas control cells entered in S phase at 16gies to identify the protease responsible for the S phase-
specific proteolytic processing of CDP/Cux. Small mole- hr (Figures 1C and 1D). Thus, expression of CDP/Cux
p110 shortens the G1 phase coming out of quiescence.cule activity-based probes (ABPs) were used to track
the activation of papain family cysteine proteases during Addition of the cysteine protease inhibitor E-64d de-
layed the entry of control cells into S phase: at 18 hr,cell cycle progression. One cysteine protease, cathepsin
L, localized to the nucleus at the G1/S transition and respectively, 24.5% and 49.3% of these cells were in S
phase in the presence or absence of E-64d (Figureswas capable of processing CDP/Cux in vitro and in vivo
to produce the physiologically relevant p110 isoform. 1C and 1E). Cells expressing CDP/Cux p110 were less
affected by the presence of E-64d, as 61.9% of theseMechanistic studies suggest that translation initiation
at downstream AUG sites allows the synthesis of shorter cells had progressed into S phase at 18 hr (Figure 1F).
These results indicate that CDP/Cux p110 can over-cathepsin L isoforms that are devoid of a signal peptide
and are targeted to the nucleus as cells progress into come, at least partially, the G1 block that is imposed
by inhibition of cysteine proteases.the cell cycle. These findings uncover a hitherto unsus-
pected function for the “lysosomal” cysteine protease
cathepsin L. Cathepsin L Can Proteolytically Process
CDP/Cux In Vitro
Proteolytic processing was previously mapped to theResults
linker region in between the CR1 and CR2 domains of
CDP/Cux, and a recombinant protein containing theseProtease Inhibitors Directed against Cathepsins
Inhibit CDP/Cux Processing domains fused to a consensus nuclear localization sig-
nal was shown to be processed following transfectionWe first tested the effect of various protease inhibitors
on the expression and activity of the CDP/Cux pro- into NIH3T3 cells (Moon et al., 2001). Purified CR1 
CR2 recombinant protein was incubated in vitro withcessed isoform p110. NIH3T3 cells were transfected
with a vector, Myc-CDP-HA, expressing the full-length a panel of cathepsins. Cleaved peptides were rapidly
generated following incubation with recombinant ca-CDP/Cux protein with Myc and HA epitope tags at its
amino and carboxy-termini, respectively. Transfected thepsin L, K, F, and V (Figure 2A). Among the ubiqui-
tously expressed cathepsins that were able to cleavecells were treated with various protease inhibitors, and
nuclear extracts were analyzed by Western blot and CR1  CR2 in vitro, F and L, cathepsin L was the most
efficient. We therefore verified whether CR1  CR2 waselectrophoretic mobility shift assay (EMSA), as pre-
viously described (Moon et al., 2001). Based on steady- cleaved similarly following transfection into NIH3T3 or
incubation in vitro with cathepsin L. The pTriEx-2 vectorstate levels of CDP/Cux p110 (Figure 1A) and the reduc-
tion in the intensity of the retarded complex (Figure 1A), (Novagen) was used to express the same CR1  CR2
protein in bacteria and mammalian cells. As seen inprocessing was inhibited by MG132 and E-64d and to
a minor extent by ALLN, cathepsin inhibitor I, and chlo- Figure 2B, the CR1  CR2 peptides generated by ca-
thepsin L in vitro displayed similar mobility on SDS-roquine. In contrast, lactacystin, PD150606, and EGTA
had no effect, suggesting that neither the proteasome PAGE as the primary peptides produced following trans-
fection into Ras-3T3 cells (compare lane 1 with lanesnor calpain were involved. The inhibitory effect of chlo-
roquine appears to involve a specific function outside 4–6). N-terminal sequencing of the cleaved peptides re-
vealed that processing occurred at three positions inof the endocytic compartments since other lysosomo-
tropic agents, like bafilomycin, bacitracin, and the pro- vitro, following residues Q643, S747, and S755 (Figure 2D).
To assess whether cathepsin L could cleave CDP/Cuxton pump inhibitor concanamycin A, did not have any
effect on CDP/Cux processing (Figure 1B). In support at neutral pH, reactions were carried at various pH using
a larger CDP/Cux substrate (Figure 2C). Although cleav-for this notion, chloroquine but neither concanamycin
A nor bafilomycin were able to inhibit CDP/Cux pro- age was more efficient at pH 5.5, substantial cleavage
was observed at pH 7.0 and 7.5. Intriguingly, in vitrocessing in an in vitro processing assay (Figure 2D). Thus,
the overall pattern of inhibition suggested that a cathep- processing of CDP/Cux at pH 7.0 was inhibited not only
by E-64d but also by chloroquine, raising the possibilitysin-like protease could be involved in the processing of
CDP/Cux. that chloroquine can directly interfere with the reaction
(Figure 2D).
Ectopic Expression of CDP/Cux p110 Overcomes a
G1-Block Imposed by a Cysteine Protease Inhibitor Steady-State Level of the CDP/Cux Processed
Isoform Correlates with Cathepsin L ExpressionTreatment of cells with a cysteine protease inhibitor was
previously reported to prevent their progression into S Coexpression of cathepsin L with Myc-CDP-HA led to
an increase in the steady-state level of CDP/Cux p110phase (Mellgren, 1997). Since processing of CDP/Cux
was shown to take place at the G1/S transition, we both in NIH3T3 (Figure 3A, lanes 1–3) and CV-1 cells
(Figure 3A, lanes 4–6). Addition of E-64d inhibited, attested whether forced expression of the processed
CDP/Cux isoform would be able to circumvent the block least partially, the production of p110 in cells (Figure
3A, lanes 6 and 7). Importantly, cotransfection with aimposed by a cysteine protease inhibitor (Moon et al.,
2001). NIH3T3 cells stably expressing a recombinant catalytically inactive mutant of cathepsin L, Cat LC25S,
did not lead to an increase in CDP/Cux p110 (Figure 3A,CDP/Cux p110 protein were synchronized by serum
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Figure 1. CDP/Cux Processing by a Papain
Family Cysteine Protease Is Required for Its
Function in Cell Cycle Regulation
(A and B) NIH3T3 cells were transfected with
a vector expressing Myc-CDP-HA. The next
day, cells were treated with cell-permeable
protease inhibitors, and after 4 hr nuclear ex-
tracts were prepared and analyzed in West-
ern blots with anti-HA antibodies (A, top
panel) and in EMSA with the ATCGAT probe
(A, bottom panel). Indicated is a schematic
representation of full-length and processed
CDP proteins (CC, coiled-coil; CR1, CR2, and
CR3: Cut repeats 1, 2, and 3; HD, homeodo-
main). (C and D) Stable populations of NIH3T3
cells carrying a p110 expression vector or an
empty vector were synchronized by serum
starvation/restimulation. In two series of plates
(E and F), the cysteine protease inhibitor
E-64d was added to a final concentration of
200 M at the same time as the fresh medium
with 10% serum. At the indicated times, cells
were harvested and cell cycle distribution
was monitored by fluorescence-activated
cell sorting (FACS) analysis after staining of
the DNA with propidium iodide.
lane 9). Proteolytic processing of Myc-CDP-HA was also of CDP/Cux processed isoforms in Cat L/ MEF cells
(Figure 3B, lanes 2–4).assessed in mouse embryo fibroblasts (MEF) derived
from the cathepsin L knockout (Roth et al., 2000). Trans-
fections were carried in parallel in Cat L/, Cat B/, The Cathepsin L Heavy Chain Is Present at Higher
Level in the Nuclear Fraction of NIH3T3and wild-type MEF cells. Proteolytic processing of Myc-
CDP-HA was much less efficient in Cat L/ MEF (Figure Cells that Are Enriched in S Phase
We investigated whether catalytically active cathepsin3B). Yet, a faint band corresponding to p110 was still
observed in Cat L/ MEF (Figure 3B, lanes 2–4). Alto- L species could be found in the nucleus. As a first ap-
proach, we used small molecule activity-based probesgether, results from gain- and loss-of-function analysis
are consistent with the notion that cathepsin L is respon- (ABPs) to radioactively label active papain family ca-
thepsins directly within cells (Bogyo et al., 2000). Thesible for the proteolytic processing of CDP/Cux. These
results do not, however, exclude the possibility that experiment was performed using populations of NIH3T3
cells synchronized at different points of the cell cycleother proteases can also proteolytically cleave CDP/
Cux as demonstrated from the presence of a low amount (Moon et al., 2001). To help determine which of the many
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Figure 2. Cathepsin L Can Proteolytically Process CDP/Cux In Vitro
(A) CR1  CR2-HA protein (200 ng) was incubated with various recombinant cathepsins (0.2 ng) for 10 at RT. Samples were analyzed by
Western blot using anti-HA antibody.
(B) Purified CR1  CR2-HA protein (200 ng) was incubated with recombinant cathepsin L (0.2 ng) for 1, 5, 10, and 30 at RT (lanes 2–6). A
nuclear extract from Ras-3T3 cells transfected with CR1  CR2-HA in shown for comparison (lane 1). In lane 7, 100 M E-64 was added to
the enzyme simultaneously with substrate.
(C) CDP/Cux 612-1328-HA was purified from bacteria and incubated with cathepsin L (0.2 ng) at various pH for the indicated times. Samples
were analyzed by Western blot using anti-HA antibody.
(D) Purified recombinant CDP/Cux 612-1328-HA was incubated with cathepsin L (0.2 ng) at pH 7.0 for 8 at RT in the presence of various inhibitors.
(E) Sequences of the cleavage sites identified by N-terminal sequencing of the protein fragments are indicated.
ABP-associated signals in NIH3T3 cells may correspond represented cathepsin L, samples from the 14 hr time
points were analyzed by immunoprecipitation with anti-to cathepsin L, the experiment was performed in parallel
with Cat L/ MEF cells. NIH3T3 cells and Cat L/ MEF cathepsin L antibodies prior to analysis by SDS-PAGE.
Two bands corresponding to the single and heavywere serum starved and then restimulated to enter the
cell cycle. At the indicated time, cells were labeled for chains of cathepsin L were present in the nuclear frac-
tion of NIH3T3 cells but were not observed in the nuclear1 hr with the ABP 125I-JPM-OET, after which cytoplasmic
and nuclear fractions were prepared and analyzed by fraction of Cat L/ MEF cells (Figure 4C). This experi-
ment was repeated using wild-type and Cat L/ MEFsSDS-PAGE and autoradiography (Figure 4). As ex-
pected, a number of bands were observed in the cyto- (Figure 4D). Autoradiography with the activity-based
probe (left panel) and immunoblotting with Cat L anti-plasmic fraction of both NIH3T3 and the Cat L/ MEF
cells (Figure 4A). Interestingly, in the nuclear fractions, bodies demonstrated that the single and heavy chain
forms of Cat L are present in the nuclear fraction of wild-two bands were present in the samples from NIH3T3
cells but were absent in the samples from Cat L/ MEF type MEFs only. Moreover, immunoblotting with anti-
Lamp1 antibodies showed that the nuclear fractionscells (Figure 4B). To verify whether these bands indeed
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Figure 3. CDP/Cux Is Proteolytically Processed by Cathepsin L In Vivo
(A) NIH3T3 and CV1 cells were transfected with the Myc-CDP-HA vector with increasing amounts of a wild-type cathepsin L vector (lanes 2,
3, 5, 6, 7, and 10). In lane 7, cells were incubated in the presence of 20 M of E-64d for 2 hr prior to harvesting. In lane 9, cells were
cotransfected with the inactive Cat L C25/S mutant. Nuclear extracts were analyzed in Western blots with anti-HA antibodies.
(B) Wild-type MEF, MEF Cat L/, and MEF cat B/ cells were transfected with the Myc-CDP-HA vector. Nuclear extracts were analyzed as
in (A).
were not contaminated with lysosomal proteins. Thus, midine block procedure, confirmed that a nuclear cathep-
sin L staining was increased in populations of cellsactive cathepsin L can be detected in the nuclear frac-
tion of cells. enriched in S phase (data not shown; see also Figure 5E).
Serial images at various depths demonstrated that the
signal originated from within the nucleus (Figure 5C). Simi-Indirect Immunofluorescence Demonstrates
that the Subcellular Localization of Cathepsin lar results were obtained with two other polyclonal cathep-
sin L antibodies directed against distinct regions of theL Varies during the Cell Cycle
Indirect immunofluorescence was performed on NIH3T3 cathepsin L protein (data not shown). Moreover, little or
no signal was detected in Cat L/ MEF cells (Figure 5D).cells using cathepsin L antibodies (Chapman et al.,
1997b). Essentially two staining patterns were observed We engineered a vector, Cat L-HA, expressing ca-
thepsin L with an HA epitope tag inserted within anin continuously growing NIH3T3 cells (Figure 5B). Ap-
proximately 80% of the cells exhibited a signal consis- external loop of the mature cathepsin L protein, at posi-
tion 216 of the cathepsin L protein sequence (Coulombetent with lysosomal localization of cathepsin L (Erickson,
1989). In 20% of the cells, a signal was also observed et al., 1996). We confirmed that cathepsin L with this
tag targets to endosomes and is secreted similarly toover the nuclear region. The observation of different
staining patterns in the same population of cells sug- wt protein (A.E., unpublished observations). Moreover,
the Cat L-HA protein expressed in the yeast Pichia pas-gested that the subcellular localization of cathepsin L
might vary throughout the cell cycle. NIH3T3 cells were toris was found to be enzymatically active (see below,
Figure 7C). Upon transfection into NIH3T3 cells, only athus synchronized by serum starvation-stimulation and
monitored by indirect immunofluorescence and FACS fraction of cells generated a signal with the anti-HA
antibody, indicating that the signal originated fromanalysis. The most frequent staining pattern for each
time point is illustrated in panel 5A, while the proportion transfected cells (Figure 5E). A proportion of cells ex-
pressing Cat L-HA displayed a signal in the nucleus,of each staining pattern is provided in panel 5B after
examination of at least 200 cells at each time point and this proportion increased following enrichment in S
phase with double thymidine block or serum stimulation(Figures 5A and 5B). We observed an increase in the
proportion of cells with a nuclear staining pattern at 12, (Figure 5E). Scanning confocal microscopy demon-
strated that the signal over the nuclear area was truly13, and 14 hr following serum addition, when a large
fraction of cells progressed beyond the G1 phase. Syn- intranuclear (data not shown). Thus, results with three
different cathepsin L antibodies and the Cat L-HA re-chronization using an alternate method, the double thy-
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Figure 4. Cathepsin L Activity in the Nucleus Increases in a Cell Cycle-Dependent Manner
(A and B) MEF Cat L/ and NIH3T3 cells were incubated for 72 hr in the absence of serum (time point 0). Serum-containing medium was
added, and, at the indicated time points, cells were incubated with 106 counts/ml 125I-JPM-OET activity-based probe for 1 hr at 37C. Cytosolic
and nuclear fractions were resolved on 14% SDS-PAGE.
(C) 125I-JPM-OET-labeled nuclear and cytosolic extracts from the 14 hr time point were subjected to immunoprecipitation using cathepsin L
antibodies (IP CL lanes) and control normal mouse serum (IP 0 lanes). Full-length cathepsin L single chain form (CLSC) and the C-terminally
truncated heavy chain form (CLHC) are labeled with arrows at right.
(D) Intact cells were labeled with the fluorescent-conjugated DCG-04 activity-based probe. Cell lysates were separated on 12% SDS-PAGE.
Gels were scanned using a Typhoon fluorescent scanner (left panel) or analyzed by immunoblotting using anti-Cat L antibodies (middle panel)
or antibodies against the lysosomal marker Lamp1 (right panel).
combinant protein revealed that cathepsin L can localize 58, 75 and 77 with UUC greatly reduced expression of
these shorter species; however, a weak band could stillto the nucleus in a cell cycle-dependent manner.
be observed (Figure 6A, lane 4). Additional replacements
at methionine codons 83 and 111 caused the disappear-Translation Can Initiate at Internal Start Sites
within the Cathepsin L mRNA ance of this band but new faster species appeared (Fig-
ure 6A, lanes 5 and 6). However, in the context of aUsing the cathepsin L cDNA in an in vitro transcription/
translation system, we detected two bands of faster cDNA in which the methionine codon 1 was left intact,
replacement of methionine codons 56, 58, 75, 77, 83,mobility that could correspond to cathepsin L proteins
generated from translation initiation at sites downstream and 111 was sufficient to eliminate expression of shorter
cathepsin L species (Figure 6A, lanes 7–9). These resultsfrom the first AUG start codon (Figure 6A, lane 2). We
performed in vitro mutagenesis to remove putative demonstrated that translation could start in vitro at sev-
eral downstream AUG initiation sites within the cathep-translation initiation sites from the cathepsin L cDNA.
The 5 portion of the murine cathepsin L cDNA contains sin L mRNA.
Following transfection of the Cat L-HA and M1-HA7 AUG codons, corresponding to methionine 1, 56, 58,
75, 77, 83, and 111. Replacement of the first AUG codon plasmids into NIH3T3, we observed cathepsin L species
of similar electrophoretic mobility as that seen in the inwith UUC (M1) prevented expression of the slowest spe-
cies, confirming that this band corresponds to the full- vitro system (Figure 6B, compare lanes 1 and 2 with
lanes 4 and 5). We then verified whether short cathepsinlength cathepsin L (Figure 6A, lane 3). Yet, the two faster
migrating species were still produced by this mutant, L proteins are expressed from the endogenous gene.
Following in vivo labeling with 35S-methionine and im-indicating that translation indeed could start at down-
stream positions. Replacement of AUG codons 56 and munoprecipitation with cathepsin L antibodies, we de-
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Figure 5. Evidence from Indirect Immunofluorescence that Cathepsin L Translocates to the Nucleus in NIH 3T3 Cells in a Cell Cycle-Depen-
dent Manner
(A) NIH3T3 cells were plated on a glass cover slips and synchronized by serum starvation/stimulation. Indirect immunofluorescence was
performed using a cathepsin L antibody and cell cycle distribution was monitored by FACS analysis as in Figure 1. (B) Two different patterns
of staining were observed. The relative percentage of cells exhibiting each staining pattern was calculated upon examination of a minimum
of 200 cells. (C) Confocal microscopy images from eight-step Z position sectional scanning of 14 hr serum-stimulated NIH3T3 cells. (D) DAPI
staining and indirect immunofluorescence using a cathepsin L antibody was performed on NIH3T3, wild-type MEF, and MEF L/ cells. (E)
NIH3T3 cells were transfected with a vector expressing cathepsin L containing an internal HA epitope (Cat L-HA). Cells were either maintained
as an unsynchronized cell population or were synchronized using either of two methods: double thymidine block followed by a 2 hr release
or serum stimulation for 13 hr following a 3 day starvation period. The relative percentage of cells exhibiting each staining pattern was
calculated upon examination of a minimum of 200 cells.
tected a faint band, which comigrated with a recombinant Cathepsin L Species Devoid of the Signal Peptide Are
Excluded from a Membrane Fraction In Vitro andshort cathepsin L species (Figure 6B, compare lane 11 with
lanes 8–10). Altogether these results suggest that transla- Exhibit a Distinct Subcellular Localization In Vivo
Cathepsin L proteins that start at amino acids 56, 58,tion in vivo can start at downstream initiation sites within
the endogenous cathepsin L mRNA, thereby allowing the 75, or 77 would not include a signal peptide and conse-
quently should be excluded from the endoplasmic retic-synthesis of cathepsin L with distinct amino termini.
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Figure 6. Translation Initiation at an Internal Start Site Allows the Expression of a Cathepsin L Isoform Devoid of the Signal Peptide
(A) Wild-type or mutated cathepsin L-HA vectors were expressed in vitro using the TNT-Promega transcription/translation system in the
presence of 35S-methionine and cysteine. Mutation numbers (M1, M56, etc.) refer to the methionine codons that were mutated (AUG to UUC).
(B) Wild-type and mutated Cat L-HA vectors were expressed in vitro as in (A) and in vivo in NIH3T3 cells. Cat L species were detected by
autoradiography or immunoblotting with an HA antibody, as indicated. Samples from NIH3T3 cells were first immunoprecipitated with Cat
L antibodies.
(C) In vitro transcription/translation with 35S-methionine was performed using the Cat L-HA or M1-HA vectors with or without (input) microsomal
membranes. Membranes and supernatant fractions were separated and Cat L isoforms were detected by autoradiography.
(D) Wild-type or mutated Cat L-HA vectors were introduced into NIH3T3 and indirect immunofluorescence was performed using anti-HA
antibody. Representative cells are shown. In the cases where more than one staining pattern was observed, the proportion of cells exhibiting
each pattern is provided.
ulum. To verify this hypothesis, in vitro translation was (Figure 6D). Remarkably, a strong nuclear signal was
never observed in cells transfected with the mutant M56-performed in the presence of a membrane fraction and
proteins were then fractionated. As expected, the full- 111-HA that expresses only the full-length cathepsin L
isoform (Figure 6D). In contrast, pancellular staining waslength cathepsin L was found mostly if not exclusively
in the membrane fraction (Figure 6C, lanes 2 and 3). In observed in all cells transfected with the M1-Cat L-HA
vector (Figure 6D). To confirm that nuclear staining wascontrast, the shorter cathepsin L produced by the mu-
tant M1 were not associated with the membrane fraction due to the expression of shorter cathepsin L species,
we engineered a vector, AUG56, in which the cathepsinand were found instead in the supernatant (Figure 6C,
lanes 5 and 6). In vivo, cells transfected with the wild- L open reading frame started at codon 56 of the wild-
type cathepsin L mRNA. One hundred percent of cellstype Cat L vector displayed two different staining pat-
terns with 20% of cells showing a distinct nuclear signal transfected with this vector displayed a strong nuclear
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staining pattern, thereby confirming that shorter cathep- Discussion
sin L species can localize to the nucleus (Figure 6D).
Expression of many cell cycle regulatory proteins is con-
trolled in large part by their degradation (Hershko, 1997).
Cathepsin L Species Devoid of the Signal Peptide In addition to this broad role of proteolysis in establish-
Stimulate the Processing and Transcriptional ing distinct patterns of protein expression, our results
Activity of CDP/Cux indicate that limited proteolysis or proteolytic pro-
Coexpression of either wild-type or M1 Cat L-HA in cessing can serve in a more subtle way to modulate the
NIH3T3 cells stimulated processing of the Myc-CDP-HA biochemical properties of specific proteins during cell
protein (Figure 7A, compare lanes 3–6 with lane 2). In cycle progression. In the case of the CDP/Cux transcrip-
contrast, increased processing was not observed with tion factor, proteolytic processing serves to generate
the M56-111-HA mutant that does not localizes to the an isoform that is capable of making a stable interaction
nucleus (Figure 7A, lanes 7–9). Overall, stimulation of with DNA and engage in distinct regulatory functions
CDP/Cux processing correlated with the expression of (Moon et al., 2001; Truscott et al., 2003). In addition, we
shorter cathepsin L-HA isoforms as seen in Figure 7B. showed in the present study that CDP/Cux p110 was
That the HA-tagged cathepsin L was enzymatically ac- able to accelerate the G1 to S transition following exit
tive was confirmed by expressing it in the yeast Pichia from quiescence (Figure 1). Thus, proteolytic processing
pastoris and testing it in the in vitro processing assay of CDP/Cux is likely to represent an important regulatory
with CR1  CR2 (Figure 7C, lane 3). step at the onset of S phase.
When wild-type cathepsin L was coexpressed with The presence of active cathepsin L in the nucleus
CDP/Cux p200, we observed an increase in the steady- raises a number of questions regarding its processing
state level of CDP/Cux p110 (Figure 7D, lane 3) and in and activity outside of the ER and lysosomal compart-
the corresponding retarded complex as seen in electro- ments. As a signal peptide is present at the N terminus
phoretic mobility shift assay (Figure 7D, lane 7). Similarly, of cathepsin L, the protein should be targeted to the
coexpression of AUG56-Cat L also led to an increase endoplasmic reticulum during its synthesis. However,
in CDP/Cux p110 expression and DNA binding activity our results revealed the existence of shorter cathepsin
(Figure 7D, lanes 12 and 17). In contrast, the M56-111 L isoforms that are devoid of the signal peptide. The
cathepsin L mutant that expresses only the full-length presence of faster migrating species that are generated
cathepsin L isoform was unable to stimulate CDP/Cux at low efficiency from the cathepsin L mRNA in the in
p110 expression and DNA binding activity (Figure 7D, vitro transcription/translation system as well as in cells
lanes 13 and 18). In summary, our results demonstrate suggested that smaller cathepsin L isoforms may be
that translation initiation at downstream start sites within expressed (Figure 6). Mutational analysis indicated that
the cathepsin L mRNA allows the synthesis of cathepsin these smaller cathepsin L isoforms were the products
L isoforms that are devoid of a signal peptide (Figures of translation initiation at downstream AUG sites by a
6A and 6B), do not transit through the endoplasmic mechanism involving either leaky scanning or internal
reticulum (Figure 6C), can localize to the nucleus (Figure ribosome entry (Figure 6). Importantly, only shorter ca-
6D), cleave the CDP/Cux transcription factor (Figure 7A), thepsin L isoforms were able to translocate to the nu-
and modify its DNA binding properties (Figure 7D). cleus and stimulate CDP/Cux processing (Figure 6). In
contrast, mutation of seven internal AUG codons lead
to the expression of a full-length cathepsin L isoform
CDP/Cux Processing in a Nuclear Fraction that did not generate a signal in the nucleus and could
Is Not Associated with Large-Scale Nuclear not stimulate CDP/Cux processing (Figure 6). Therefore,
Protein Degradation we conclude that translation initiation at downstream
The presence of active cathepsin L in the nucleus raises AUG sites within the cathepsin L mRNA is the first re-
an important question regarding its specificity in this quirement in the chain of events that lead to the pres-
compartment: does cathepsin L cleave all proteins or ence of active cathepsin L in the nucleus.
only a limited set? To begin to address this issue, puri- A major obstacle to the correct folding and processing
fied cathepsin L was added to a nuclear extract at neu- of shorter cathepsin L outside of the endoplasmic reticu-
tral pH to the point where it processed CDP/Cux, and lum and lysosomes presumably would be the different
2D PAGE analysis was performed to assess the effect redox potential and neutral pH of the cytoplasmic and
of cathepsin L on nuclear proteins in general. Western nuclear milieu. While most studies on this subject have
blot analysis demonstrated that CDP/Cux was efficiently focused on activation of cathepsin L in the endosomes,
processed in these conditions (Figure 7E). Comparison proper maturation of this protease elsewhere is not im-
of nuclear proteins incubated or not with cathepsin L possible in light of the demonstrated autocatalytic pro-
indicated that less than 10% of the spots disappeared cessing of cathepsin L in vitro (Menard et al., 1998). In
or were reduced in intensity, while an equivalent number the latter study, autocatalytic processing required that
of additional spots were detected (Figure 7E). Thus, in- the pH be reduced to 5.3, a situation that is unlikely to
cubation of active cathepsin L with nuclear extracts at be found in the cytoplasm or the nucleus. However, we
pH 7 caused the cleavage of only a small fraction of speculate that a shorter cathepsin L prodomain does
nuclear proteins. As the specificity of cathepsin L is not bind as tightly to the active groove, thereby allowing
likely to be higher in vivo in the context of a compartmen- autocatalytic processing at higher pH. In support for
talized nucleus, these findings strongly suggest that the this notion, a shorter form of cathepsin B that lacks the
presence of cathepsin L in the nucleus is not associated signal peptide and part of the propeptide (52 residues)
was shown to fold properly and become active (Mehtaniwith large-scale protein degradation.
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Figure 7. Short Cathepsin L Isoforms Can Process CDP/Cux and Increase Its DNA Binding Activity
(A) NIH3T3 cells were transfected with the Myc-CDP-HA vector with increasing amounts of wild-type or mutated Cat L-HA vectors. Nuclear
extracts were analyzed by Western blot using anti-HA antibody.
(B) Total extracts were first submitted to immunoprecipitation with Cat L antibodies and then to immunoblotting with HA antibodies.
(C) For 10 min at 37C, 250 ng of bacterially purified CR1  2-HA protein was incubated with 1 l of media from either wild-type or Cat L-HA
expressing Pichia pastoris in the presence or absence of E-64d. Reactions were analyzed by Western blot using anti-Myc antibodies. A
nuclear extract from Ras-3T3 cells transfected with CR1  CR2-HA in shown for comparison (lane 1).
(D) NIH3T3 cells were transfected with Myc-CDP-HA vector with or without wild-type or mutated Cat L vectors. Nuclear extracts were analyzed
in Western blots with anti-HA antibodies and in EMSA as described in Figure 1.
(E) For 30 at RT, 55 g of nuclear extracts (NE) from Myc-CDP-HA expressing NIH3T3 cells were incubated in the presence or absence of
cathepsin L (200 ng). An aliquot of 5 g was analyzed by immunoblotting with anti-HA antibodies and Coomassie blue staining. The rest of
the extract was precipitated by TCA and subjected to two-dimensional electrophoresis. Gels were stained with Sypro Ruby.
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were lysed in buffer AE (0.6% SDS, 50 mM Tris [pH 8], 100 mMet al., 1998). As the cytosolic chaperone machinery is
NaCl, 2 mM EDTA) supplemented with a Complete Mini proteaserecruited while the nascent protein is still on the ribo-
inhibitor cocktail tablet (Roche).some, we envisage the possibility that cytosolic chaper-
ones somehow serve as substitutes for the proregion Immunoprecipitation
(Frydman, 2001). Furthermore, recent evidence sug- Polyclonal antibodies for cathepsin L (Chapman et al., 1997b) were
gests that a redox potential might be available in the incubated with cell extracts in AE buffer supplemented with 4%
Triton X-100 and 8 mM iodoacetamide for 90 min.cytosol, as members of the protein disulfide isomerase
(PDI) family were found in non-ER locations, including
Cathepsin Activity Labelingthe cytosol and the nucleus (reviewed in Turano et al.,
Cathepsin activity was measured using a small activity-based probe2002). In relation to this, a number of studies have also
(ABP) as previously described (Bogyo et al., 2000).
raised the intriguing possibility that cell cycle progres-
sion from the G1 to the S phase may be associated with Western Blot Analysis
overall cellular (or nuclear) metabolic state/redox status Protein extracts were separated by electrophoresis on 6% (CDP/
(Menon et al., 2003; Zheng et al., 2003). Cux), 8% (CR1  2 and 612–1328), 12%, or 14% (cathepsin L)
polyacrylamide gels. Western blot analyses with HA (1/1000), MycCan cathepsin L be a functional enzyme at neutral
(1/1000), and 861 (1/1000) were performed as in Moon et al. (2001)pH? Since optimal enzymatic activity by cathepsins is
and with cathepsin L antibodies (1/20000) as in Chapman et al.achieved at a pH 5.5, we can reasonably assume that
(1997b).
cathepsins might only be weakly active in the nuclear
milieu (Turk et al., 1997). Yet, using partially purified CDP/Cux In Vitro Cleavage Assay and Cleavage
cathepsin L from two independent sources, rat liver and Site Determination
the yeast Pichia pastoris, we have shown that cathepsin In reaction buffer I (50 mM acetate buffer, 5 mM DTT [pH 5.5]) 200
ng of bacterially purified CR1CR2 were incubated with 0.2 ng ofL is able to process a CDP/Cux substrate at neutral pH,
recombinant cathepsin L. Similar assays were performed in thealthough a reduction in activity was observed at pH 7.5
presence of the recombinant cathepsins B, H, K, F, V, and S. Otherrelative to pH 5.5 (Figures 2C, 7C, 7E, and data not
buffers were used when the assay was performed at other pH: 50
shown). We emphasize that limited cathepsin L activity mM MES at pH 5.5–6.5 and 50 mM HEPES at pH 7.0 and 7.5. To
in the nucleus is entirely compatible with a role in the determine the sequence of cleavage sites, in vitro-generated CDP
proteolytic processing of specific nuclear proteins. In cleavage products were blotted onto a PVDF membrane and sub-
jected to N-terminal sequencing by Edman degradation.contrast, optimal activity of cathepsins in the acidic envi-
ronment of the lysosome is necessary for the terminal
Two-Dimensional Electrophoresisdegradation of proteins. Thus, the suboptimal pH that
Immobilized pH gradient (IPG) strips (pH 3–10, 18 cm) were preparedprevails in the nucleus should not be taken as an obsta-
according to the manufacturer protocol (Amersham Pharmacia Bio-cle but rather as an important element that enables ca-
tech). Isoelectric focusing was performed on an IPGphore system
thepsin L to play a role in the limited proteolysis of (Amersham Pharmacia Biotech). SDS-PAGE in the second dimen-
nuclear proteins. Future studies should investigate the sion was performed in 8% acrylamide. Gels were stained using
possibility that other cysteine proteases might be pres- SYPRO Ruby according to the manufacturer protocol (Molecular
Probes).ent in the nucleus. In agreement with this notion, we
observed a small amount of the CDP/Cux p110 isoform
Electrophoretic Mobility Shift Assayin Cat L/ MEF cells (Figure 3B). It is possible that
EMSA performed using 1 g of nuclear extracts from transfectedredundant protease activities coexist in the nucleus in
NIH3T3 as described (Moon et al., 2001).
a somewhat constitutive manner; alternatively, gene in-
activation of cathepsin L may lead to the compensatory Plasmid Construction
induction of other proteases, like cathepsin F, for exam- Plasmids, maps, and sequences will be provided upon request.
ple. We note that the coding sequences of cathepsin F CDP constructs Myc-CDP-HA, 878–1505, and 612–1328 have been
described (Hebert et al., 2003; Moon et al., 2001). pTriEx-2/His-and V contain, like cathepsin L, several AUG codons
CR1  2-NLS-HA (Figure 2) contains a histidine tag, CDP aminothat are located downstream of the first AUG codons.
acids 527–1027, a synthetic NLS (ALKKKRKV), and an HA tag. ThisOverall, our results should trigger a reevaluation of the
clone was modified for Figure 7 by insertion of a Myc tag down-subcellular localization of cathepsins. While it is clear
stream of the HA tag. The mouse Cat L cDNA was inserted into the
that the principal activity of cathepsins takes place in BamH1 site of pCDNA3 (InVitrogen). Cat L mutants were generated
the lysosomes, it is possible that alternative isoforms with the following substitutions: AUG codons (Met 1, 56, 58, 75, 77,
might avoid targeting to the ER. We further speculate 82, 111) were mutated to UUC (Phe) and the UGC codon of Cys 25
to UCC (Ser). AUG 56-HA was generated by PCR amplification usingthat some of the phenotypes observed in the various
Cat L-HA as a template and a primer containing a Kozak consensuscathepsins mutant mice might involve biochemical ac-
followed by Cat L sequences starting at AUG 56.tivities in other cellular compartments.
Pichia pastoris Expression SystemExperimental Procedures
Cat L-HA was introduced into the pPIC9 vector and recombinant
yeast were generated and selected using the manufacturer’s in-Cell Culture
structions (InVitrogen). The in vitro processing assays were per-Cell culture, synchronizations, and FACS analysis were performed
formed at pH 7.0.as previously described (Coqueret et al., 1998; Stein and Borun,
1972). Populations of NIH3T3 cells having stably integrated pREV/
ImmunofluorescenceTRE-CDP/Cux 1–1505, 878–1505, or the empty pREV/TRE vector
NIH3T3, MEF/, or MEF L/ cells were plated on cover slips and(Clontech) were generated by retroviral infection.
transfected or not with 5 g of wild-type or mutant pCDNA3-CatL-
HA. Cells were fixed with 2% paraformaldehyde and quenched inPreparation of Cell Extracts
50 mM of NH4Cl. Cells were solubilized (95% PBS  5% FBS Nuclear extracts were prepared according to the procedure of Lee
et al. (1988) as described (Moon et al., 2001). For total extracts, cells 0.5% Triton X-100) and incubated with Cat L (1:1000) (Chapman
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et al., 1997b), Santa Cruz D20 (1/200), Santa Cruz M19 (1/200), or Hebert, S., Bérubé, G., and Nepveu, A. (2003). Development of an
in vitro assay for the proteolytic processing of the CDP/Cux tran-HA (1:20000) for 1 hr at RT. Secondary antibody (anti-mouse alexia
488 1:1000 or anti-rabbit alexia 594) was added for 30 min. Cells scription factor. J. Biochem. Mol. Biol. 36, 390–398.
were visualized using a Zeiss AxioVert 135 microscope with a 63 Hershko, A. (1997). Roles of ubiquitin-mediated proteolysis in cell
objective or using a Zeiss LSM 510 confocal microscope. cycle control. Curr. Opin. Cell Biol. 9, 788–799.
Holthuis, J., Owen, T.A., van Wijnen, A.J., Wright, K.L., Ramsey-
In Vitro Transcription/Translation Ewing, A., Kennedy, M.B., Carter, R., Cosenza, S.C., Soprano, K.J.,
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